The molecular link between β- and γ-secretase activity on the amyloid β precursor protein

Cellular and Molecular Life Sciences

Volumn 64, Issue 17, 2007, Pages 2211-2218

  Tabaton, M ^a   Tamagno, E ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

secretase; Alzheimer's disease; Amyloid ; BACE1; Oxidative stress; PS1

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; PRESENILIN 1;

ALZHEIMER DISEASE; ENZYME ACTIVITY; FAMILIAL DISEASE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; HUMANS; OXIDATIVE STRESS; PRESENILINS;

EID: 34548306686     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7219-3     Document Type: Review

References (77)

1. Weidemann, A., Eggert, S., Reinhard, F. B., Vogel, M., Paliga, K., Baier, G., Masters, C. L., Beyreuther, K. and Evin, G. (2002) A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41, 2825-2835.
2. Leissring, M. A., Murphy, M. P., Mead, T. R., Akbari, Y., Sugarman, M. C., Jannatipour, M., Anliker, B., Muller, U., Saftig, P., De Strooper, B. et al. (2002) A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP. Proc. Natl. Acad. Sci. USA 99, 4697-4702.
3. Mattson, M. P. (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
4. Zhao, G., Mao, G., Tan, J., Dong, J., Cui, M. Z., Kim, S. H. and Xu, X. (2004) Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein. J. Biol. Chem. 279, 50647-50650.
5. Zhao, G., Cui, M. Z., Mao, G., Dong, Y., Tan, J., Sun, L. and Xu, X. (2005) γ-Cleavage is dependent on ζ-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain. J. Biol. Chem. 280, 37689-37697.
6. Yankner, B. A. (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
7. Shahani, N., Subramaniam, S., Wolf, T., Tackenberg, C. and Brandt, R. (2006) Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices. J. Neurosci. 26, 6130-6134.
8. Chun, W. and Johnson, G. V. ( 2007) The role of tau phosphorylation and cleavage in neuronal cell death. Front. Biosci. 12, 733-756.
9. Goate, A. (2006) Segregation of a missense mutation in the amyloid beta-protein precursor gene familial Alzheimer's disease. J. Alzheimer Dis. 9, 341-347.
10. Huang, Y., Weisgraber, K. H., Mucke, L. and Mahley, R. W. (2004) Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J. Mol. Neurosci. 23, 189-204.
11. De Strooper, B. (2007) Loss-of-function presenilin mutations in Alzheimer's disease. Talking point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 8, 141-146.
12. Sultana, R., Perluigi, M. and Butterfield, D. A. (2006) Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antiox. Redox Signal. 8, 2021-2037.
13. Blass, J. P., Gibson, G. E. and Hoyer, S. (2002) The role of the metabolic lesion in Alzheimer's disease. J. Alzheimer Dis. 4, 225-232.
14. Kawahara, M. (2004) Disruption of calcium homeostasis in the pathogenesis of Alzheimer's disease and other conformational diseases. Curr. Alzheimer Res. 1, 87-95.
15. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R. et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
16. Bennett, B. D., Denis, P., Haniu, M., Teplow, D. B., Kahn, S., Louis, J. C. Citron, M. and Vassar, R. (2000) A furin-like convertase mediates propeptide cleavage of BACE the Alzheimer's beta secretase. J. Biol. Chem. 275, 37712-37717.
17. Creemers, J. W., Ines Dominguez, D., Plets, E., Serneels, L., Taylor, N. A., Multhaup, G., Craessaerts, K. M., Annaert, W. and De Strooper, B. (2001) Processing of beta-secretase by furin and other members of the proprotein convertase family. J. Biol. Chem. 276, 4211-4217.
18. Walter, J., Fluhrer, R., Hartung, B., Willem, M., Kaether, C., Capell, A., Lammich, S., Multhaup, G. and Haass, C. (2001) Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem. 276, 14634-14641.
19. Capell, A., Steiner, H., Willem, M., Kaiser, H., Meyer, C., Walter, J., Lammich, S., Multhaup, G. and Haass, C. (2000) Maturation and pro-peptide cleavage of beta secretase. J. Biol. Chem. 275, 30949-30854.
20. Benjannet, S., Elagoz, A., Wuickham, L., Mamarbachi, M., Munzer, J. S., Basak, A., Lazure, C., Cromlish, J. A., Sisodia, S., Checler, C. et al. (2001) Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276, 10879-10887.
21. Huse, J. T., Pijak, D. S., Leslie, G. J., Lee, V. M. and Doms, R. W. (2000) Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J. Biol. Chem. 275, 33729-33737.
22. Pastorino, L., Ikin, A. F., Nairn, A. C., Pursnani, A. and Buxbaum, J. D. (2002) The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta). Mol. Cell. Neurosci. 19, 175-185.
23. He, X., Li, F., Chang, W. P. and Tang, J. (2005) GGA proteins mediate the recycling of memapsin 2 (BACE). J. Biol. Chem. 280, 11696-11703.
24. Marlow, L., Cain, M., Pappolla, M. A. and Sambamurti, K. (2003) Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP). J. Mol. Neurosci. 20, 233-239.
25. Spoelgen, R., von Arnim, C. A., Thomas, A. V., Peltan, I. D., Koker, M., Deng, A., Irizzarry, M. C., Andersen, O. M., Willnow, T. E. and Hyman, B. T. (2006) Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J. Neurosci. 26, 418-428.
26. Vassar, R. (2001) The beta-secretase, BACE: a prime target for Alzheimer's disease. J. Mol. Neurosci. 17, 157-170.
27. Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., Chen, K. S., Freedman, S. B., Frigon, N. L., Games, D., Hu, K. et al. (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 1317-1324.
28. Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C. and Haass, C. (2006) Control of peripheral nerve myelination by the b-secretase BACE1. Science 314, 664-666.
29. Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M. et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
30. Dewji, N. N. (2005) The structure and functions of the presenilins. Cell. Mol. Life Sci. 62, 1109-1119.
31. Verdile, G., Gandy, S. E. and Martins, R. N. (2007) The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochem. Res. 32, 609-623.
32. De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K. and Van Leuven, F. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390.
33. Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H. et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. USA 96, 11872-11877.
34. Mastrangelo, P., Mathews, P. M., Chishti, M. A., Schmidt, S. D., Gu, Y., Yang, J., Mazzella, M. J., Coomaraswamy, J., Horne, P., Strome, B. et al. (2005) Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases. Proc. Natl. Acad. Sci. USA 102, 8972-8977.
35. Edbauer, D., Winkler, E., Haass, C. and Steiner, H. (2002) Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc. Natl. Acad. Sci. USA 99, 8666-8671.
36. Francis, R., McGrath, G., Zhang, J., Ruddy, D. A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M. C. et al. (2002) Aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3, 85-97.
37. Goutte, C., Hepler, W., Mickey, K. M. and Priess, J. R. (2000) Aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling. Development 127, 2481-2492.
38. Hu, Y. and Fortini, M. E. (2003) Different cofactor activities in gamma-secretase assembly: evidence for a nicastrin-Aph-1 subcomplex. J. Cell Biol. 161, 685-690.
39. Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G. and Iwatsubo, T. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature 422, 438-441.
40. Holsinger, R. M., McLean, C. A, Beyreuther, K., Masters, C. L. and Evin, G. (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer's Disease. Ann. Neurol. 51, 783-786.
41. Fukumoto, H., Cheung, B. S., Hyman, B. T. and Irizarry, M. C. (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 1381-1389.
42. Yang, L. B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X. L., Beach, T., Sue, L., Wong, P., Price, D. et al. (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 3-4.
43. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A. and Butterfield, D. A. (1994) Amodel for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
44. Floyd, R. A. and Hensley, K. (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795-807.
45. Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K. and Mattson, M. P. (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid betapeptide. J. Neurochem. 68, 255-264.
46. Tabner, B. J., El-Agnaf, O. M., Turnbull, S., German, M. J., Paleologou, K. E., Hayashi, Y., Cooper, L. J., Fullwood, N. J. and Allsop D (2005) Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer's disease and familial British dementia. J. Biol. Chem. 280, 35789-35792.
47. Murakami, K., Irie, K., Ohigashi, H., Hara, H., Nagao, M., Shimizu, T. and Shirasawa T(2005) Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's disease. J. Am. Chem. Soc. 127, 15168-15174.
48. Paola, D., Domenicotti, C., Nitti, M., Vitali, A., Borghi, R., Cottalasso, D., Zaccheo, D., Odetti, P., Strocchi, P., Marinari, U. M. et al. (2000) Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 268, 642-646.
49. Tamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., Perry, G. and Tabaton, M. (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628-636.
50. Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X. and Song, W. (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural. Transm. 112, 455-469.
51. Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G. et al. (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10, 279-288.
52. Tamagno, E., Guglielmotto, M., Bardini, P., Santoro, G., Davit, A., Di Simone, D., Danni O. and Tabaton, M. (2003) Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress. Neurobiol. Dis. 14, 291-301.
53. Guo, Q., Sopher, B. L., Furukawa, K., Pham, D. G., Robinson, N., Martin, G. M. and Mattson, M. P. (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222.
54. Weihl, C. C., Ghadge, G. D., Kennedy, S. G., Hay, N., Miller, R. J. and Roos, R. P. (1999) Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J. Neurosci. 19, 5360-5369.
55. Moehlmann, T., Winkler, E., Xia, X., Edbauer, D., Murrell, J., Capell, A., Kaether, C., Zheng, H., Ghetti, B., Haass, C. et al. (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc. Natl. Acad. Sci. USA 99, 8025-8030.
56. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L. et al. (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140.
57. Sadowski, M., Pankiewicz, J., Scholtzova, H., Ji, Y., Quartermain, D., Jensen, C. H., Duff, K., Nixon, R. A., Gruen, R. J. and Wisniewski, T. (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. J. Neuropathol. Exp. Neurol. 63, 418-428.
58. Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P. and Selkoe, D. J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93, 13170-13175.
59. Schuessel, K., Frey, C., Jourdan, C., Keil, U., Weber, C. C., Muller-Spahn, F., Muller, W. E. and Eckert, A. (2006) Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. Free Radic. Biol. Med. 40, 850-862.
60. Begley, J. G., Duan, W., Chan, S., Duff, K. and Mattson, M. P. (1999) Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72, 1030-1039.
61. Mohmmad Abdul, H., Wenk, G. L., Gramling, M., Hauss-Wegrzyniak, B. and Butterfield, D. A. (2004) APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease. Neurosci. Lett. 368, 148-150
62. Assini, A., Terreni, L., Borghi, R., Giliberto, L., Piccini, A., Loqui, D., Fogliarino, S., Forloni, G. and Tabaton, M. (2003) Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation. Neurology 60, 150-151.
63. Crook, R., Verkkoniemi, A., Perez-Tur, J., Mehta, N., Baker, M., Houlden, H., Farrer, M., Hutton, M., Lincoln, S., Hardy, J. et al. (1998) A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 4, 452-455.
64. Kwok, J. B., Taddei, K., Hallupp, M., Fisher, C., Brooks, W. S., Broe, G. A., Hardy, J., Fulham, M. J., Nicholson, G. A., Stell, R. et al. (1997) Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 8, 1537-1542.
65. Sodeyama, N., Iwata, T., Ishikawa, K., Mizusawa, H., Yamada, M., Itoh, Y., Otomo, E., Matsushita, M. and Komatsuzaki, Y. (2001) Very early onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin 1 mutation (Phe237Ile). J. Neurol. Neurosurg. Psychiatry 71, 556-557.
66. Houlden, H., Baker, M., McGowan, E., Lewis, P., Hutton, M., Crook, R., Wood, N. W., Kumar-Singh, S., Geddes, J., Swash, M. et al. (2000) Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann. Neurol. 48, 806-808.
67. Piccini, A., Russo, C., Gliozzi, A., Relini, A., Vitali, A., Borghi, R., Giliberto, L., Armirotti, A., D'Arrigo, C., Bachi, A. et al. (2005) Beta-amyloid is different in normal aging and in Alzheimer disease. J. Biol. Chem. 280, 34186-34192.
68. Piccini, A., Zanussi, G., Borghi, R., Novello, C., Monaco, S., Russo, R., Da Monte, G., Armirotti, A., Gelati, M., Giordano, R. et al. (2007) A presenilin 1S170F mutation is associated with a novel Alzheimer's disease molecular phenotype. Arch Neurosci. 64, 738-745.
69. Lee, E. B., Skovronsky, D. M., Abtahian, F., Doms, R. W. and Lee, V. M. (2003) Secretion and intracellular generated of truncated Abeta in beta-site amyloid-beta precursors protein-cleaving enzyme expressing human neurons. J. Biol. Chem. 278, 4458-4466.
70. Kamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A. and Goldstein, L. S. (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414, 643-648.
71. Kuzuya, A., Uemura, K., Kitagawa, N., Aoyagi, N., Kihara, T., Ninomiya, H., Ishiura, S., Takahashi, R. and Shimohama, S. (2007) Presenilin 1 is involved in the maturation of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1). J. Neurosci. Res. 85, 153-165.
72. Minopoli, G., Stante, M., Napolitano, F., Telese, F., Aloia, L., De Felice, M., Di Lauro, R., Pacelli, R., Brunetti, A., Zambrano, N. et al. (2006) Essential roles for Fe65, Alzheimer amyloid precursor-binding protein, in the cellular response to DNA damage. J. Biol. Chem. 282, 831-835.
73. Russo, C., Schettini, G., Saido, T. C., Hulette, C., Lippa, C., Lannfelt, L., Ghetti, B., Gambetti, P., Tabaton, M. and Teller, J. K. (2000) Presenilin-1 mutations in Alzheimer's disease. Nature 405, 531-532.
74. Tamagno, E., Bardini, P., Guglielmotto, M., Danni, O. and Tabaton, M. (2006) The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic. Biol. Med. 41, 202-212.
75. Ramsden, M., Plant, L. D., Webster, N. J., Vaughan, P. F., Henderson, Z. and Pearson, H. A. (2001) Differential effects of unaggregated and aggregated amyloid beta protein (1-40) on K(+) channel currents in primary cultures of rat cerebellar granule and cortical neurones. J. Neurochem. 79, 699-712.
76. Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C. and Pearson, H. A. (2003) The production of amyloid beta peptide is a critical requirement for the viability of central neurons. J. Neurosci. 23, 5531-5535.
77. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S. and Malinow, R. (2003) APP processing and synaptic function. Neuron 37, 925-937.